Drug intelligence / Profile preview

advanced platelet-rich fibrin

Development stage
Phase 4
Lead developer
King AbdulAziz University
Modality
Cell Therapies
Administration
Surgical Implantation, Topical, Intra-articular Injection, Intradermal Injection, Subcutaneous Injection, Peri-lesional Injection
01

Overview

Advanced platelet-rich fibrin (aPRF) is a second-generation autologous platelet concentrate produced by centrifuging whole blood without the use of anticoagulants. Unlike first-generation platelet-rich plasma (PRP), aPRF forms a dense fibrin matrix that traps platelets, growth factors, and leukocytes (specifically neutrophils). This matrix acts as a bioactive scaffold that provides a sustained release of regenerative molecules, including PDGF, TGF-β, and VEGF, over an extended period of up to 28 days. The inclusion of neutrophils contributes to monocyte/macrophage differentiation, tissue repair, and angiogenesis. While traditionally utilized in oral and maxillofacial surgery for bone grafting and socket preservation, aPRF is increasingly investigated for dermatological applications such as alopecia areata and androgenetic alopecia, often requiring micronization techniques to facilitate injection through fine-gauge needles.

Brand names
Advanced PRFA-PRF
Other names
aPRFA-PRFadvanced PRFplatelet-rich fibrin

Beyond the preview

Go deeper on advanced platelet-rich fibrin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on advanced platelet-rich fibrin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call